Brendan P. Eckelman Transaction History

Date Transaction Value Shares Traded Form
May 30 2024
SELL
Sale (or disposition) back to the issuer
$61,666,590 $30.0 p/Share
2,055,553
May 28 2024
SELL
Open market or private sale
$10,290,000 $34.3 p/Share
300,000
Mar 01 2023
SELL
Open market or private sale
$978,400 $24.46 p/Share
40,000
Feb 02 2023
SELL
Open market or private sale
$288,562 $25.65 p/Share
11,250
Feb 01 2023
SELL
Open market or private sale
$719,037 $25.01 p/Share
28,750
Jan 04 2023
SELL
Open market or private sale
$167,322 $23.55 p/Share
7,105
Jan 03 2023
SELL
Open market or private sale
$799,019 $24.29 p/Share
32,895
Dec 06 2022
SELL
Open market or private sale
$1,104,800 $27.62 p/Share
40,000
Nov 01 2022
SELL
Open market or private sale
$1,344,800 $33.62 p/Share
40,000
Oct 04 2022
SELL
Open market or private sale
$1,111,200 $27.78 p/Share
40,000
Sep 13 2022
SELL
Bona fide gift
-
160,000
Sep 13 2022
BUY
Bona fide gift
-
160,000
Sep 06 2022
SELL
Open market or private sale
$610,400 $15.26 p/Share
40,000
Aug 03 2022
SELL
Open market or private sale
$286,285 $18.47 p/Share
15,500
Aug 02 2022
SELL
Open market or private sale
$433,650 $17.7 p/Share
24,500
Jul 07 2022
SELL
Open market or private sale
$686,800 $17.17 p/Share
40,000
Apr 05 2022
SELL
Open market or private sale
$10,016 $25.04 p/Share
400
Mar 24 2021
SELL
Open market or private sale
$323,340 $19.02 p/Share
17,000
Feb 16 2021
SELL
Open market or private sale
$440,300 $25.9 p/Share
17,000
Dec 04 2020
SELL
Bona fide gift
-
160,000
Dec 04 2020
BUY
Bona fide gift
-
160,000

Also insider at

INXB
Inhibrx Biosciences, Inc.
BPE

Brendan P. Eckelman

Chief Scientific Officer
La Jolla, CA

Track Institutional and Insider Activities on INBX

Follow Inhibrx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INBX shares.

Notify only if

Insider Trading

Get notified when an Inhibrx, Inc. insider buys or sells INBX shares.

Notify only if

News

Receive news related to Inhibrx, Inc.

Track Activities on INBX